Enhanced microbial production of pyridoxine (Vitamin B6) in Bacillus subtilis via pathway and process optimization
Synthetic and Systems Biotechnology · 2026-03 · 11 · 216-225
DOI: 10.1016/j.synbio.2025.09.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthetic and Systems Biotechnology, 2026-03. Verfasst von Ai-Tong Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Engineering, Dalian Polytechnic University, Dalian, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund for Distinguished Young Scholars, National Key Research and Development Program of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Vitamin B6 refers to a family of water-soluble B vitamin, which is essential for various physiological functions, including amino acid metabolism, neurotransmitter synthesis, and hemoglobin synthesis. The biosynthesis of pyridoxine (PN), a commercial form of vitamin B6, through microbial fermentation has garnered widespread attention owing to its environmentally friendly and safe production methods, as well as its mild reaction conditions. However, the low yield of natural strains limits their application. This study focused on constructing a high-yielding strain of PN through pathway engineering and process optimization. Firstly, five key deoxyxylulose-5-phosphate-dependent pathway genes (epd, pdxB, serC, pdxA, and pdxJ) were overexpressed in Bacillus subtilis ARTP, which improved the PN titer by 3.2-fold to 2.9 mg/L. Subsequently, pdxST genes involved in the DXP-independent pathway were screened from various strains. Ribosome binding site (RBS) sequences were optimized to regulate their expression, which further increased the PN titer to 24.6 mg/L. Finally, systematic medium optimization was identified as a critical strategy for enhancing PN biosynthesis, leading to a remarkable 1.8-fold improvement in PN production. Under optimized fermentation conditions, the engineered strain achieved a PN titer of 174.6 mg/L in fed-batch fermentation, which represents the highest level reported to date in B. subtilis. Overall, this study presents an effective strategy combining pathway engineering and medium optimization for significantly improving PN production, offering valuable insights for the industrial development of PN biosynthesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biological Engineering, Dalian Polytechnic University, Dalian, China.
- Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
- National Center of Technology Innovation for Synthetic Biology, Tianjin, China.
- State Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
- University of Chinese Academy of Sciences, Beijing, China.
Förderung
- National Science Fund for Distinguished Young Scholars
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Jiang, A. T., Du, G. Q., Huang, X. Y., Ji, Z. Z., Qian, S. R., Liu, L. X., & Zhang, D. W. (2026). Enhanced microbial production of pyridoxine (Vitamin B6) in Bacillus subtilis via pathway and process optimization. Synthetic and Systems Biotechnology, 11, 216-225. https://doi.org/10.1016/j.synbio.2025.09.014
Vancouver
Jiang AT, Du GQ, Huang XY, Ji ZZ, Qian SR, Liu LX, et al. Enhanced microbial production of pyridoxine (Vitamin B6) in Bacillus subtilis via pathway and process optimization. Synthetic and Systems Biotechnology. 2026;11:216-225. doi:10.1016/j.synbio.2025.09.014
BibTeX
@article{Jiang2026,
author = {Jiang, Ai-Tong and Du, Guang-Qing and Huang, Xu-Yang and Ji, Zheng-Zi and Qian, Si-Riguleng and Liu, Lin-Xia and Zhang, Da-Wei},
title = {Enhanced microbial production of pyridoxine (Vitamin B6) in Bacillus subtilis via pathway and process optimization},
journal = {Synthetic and Systems Biotechnology},
year = {2026},
volume = {11},
pages = {216--225},
doi = {10.1016/j.synbio.2025.09.014}
}
EUVIMED